| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/01/2013 | US8343916 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 01/01/2013 | US8343915 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 01/01/2013 | US8343914 Fibrillation resistant proteins |
| 01/01/2013 | US8343913 Hsp90, buffering and drug resistance |
| 01/01/2013 | US8343912 Antibiotic compositions for the treatment of gram negative infections |
| 01/01/2013 | US8343911 Methods of inhibiting and treating bacterial biofilms by metal chelators |
| 01/01/2013 | US8343910 Reversible pegylated drugs |
| 01/01/2013 | US8343760 p53 activator peptides |
| 01/01/2013 | US8343745 Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof |
| 01/01/2013 | US8343743 Designer ubiquitin ligases having a non-cleavable SNAP25 domain and E3-ligase domain |
| 01/01/2013 | US8343737 Cell culture compositions capable of producing a VEGF-binding fusion polypeptide |
| 01/01/2013 | US8343541 Ubiquinol and alpha lipoic acid compositions |
| 01/01/2013 | US8343531 Composition containing peptide as active ingredient |
| 01/01/2013 | US8343513 Mixture of polymer and drug with acid adjuvant |
| 01/01/2013 | US8343504 methods and materials for treating conditions associated with IgE activation in humans and animals, and to agents capable of modulating the activation. The agents of the invention comprise or are related to IGBPMA polypeptides from ticks. |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343501 Bispecific EGFR/IGFIR binding molecules |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 01/01/2013 | US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
| 01/01/2013 | US8343487 Large-scale production of soluble hyaluronidase |
| 01/01/2013 | US8343486 Methods and compositions for topical treatment of medical conditions including wounds and inflammation |
| 01/01/2013 | US8343483 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 01/01/2013 | US8343479 Using hematopoietic stem cells to restore functional and structural integrity to damaged myocardium; tissue engineering; tissue repair; regenerative medicine |
| 01/01/2013 | US8343478 Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases |
| 01/01/2013 | US8343477 Viricides; serine protease inhibitors |
| 01/01/2013 | US8343476 Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B |
| 01/01/2013 | US8343475 Small cationic antimicrobial peptides |
| 12/28/2012 | CA2795995A1 Microneedle assembly formulation for skin treatment |
| 12/27/2012 | WO2012178160A2 Materials and methods for modulating immune responses |
| 12/27/2012 | WO2012178151A2 St6gal i mediated modulation of hematopoiesis |
| 12/27/2012 | WO2012178146A1 Compositions and methods for treatment of spinal muscular atrophy |
| 12/27/2012 | WO2012178102A2 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
| 12/27/2012 | WO2012178083A1 Methods of treating chronic disorders with complement inhibitors |
| 12/27/2012 | WO2012178078A2 Use of yscf, truncated yscf and yscf homologs as adjuvants |
| 12/27/2012 | WO2012178063A1 Compound and method for modulating opioid receptor activity |
| 12/27/2012 | WO2012178033A2 Serpina1 sirnas: compositions of matter and methods of treatment |
| 12/27/2012 | WO2012178022A2 Therapeutic applications targeting sarm1 |
| 12/27/2012 | WO2012177949A2 Compositions and methods for inhibition of expression of protein c (proc) genes |
| 12/27/2012 | WO2012177947A2 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes |
| 12/27/2012 | WO2012177921A2 Compositions and methods for inhibiting hepcidin antimicrobial peptide (hamp) or hamp-related gene expression |
| 12/27/2012 | WO2012177903A2 Methods of treating cognitive impairment |
| 12/27/2012 | WO2012177892A2 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis |
| 12/27/2012 | WO2012177856A2 Cognition modification |
| 12/27/2012 | WO2012177784A2 Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof |
| 12/27/2012 | WO2012177770A1 Bipartite inhibitors of bacterial rna polymerase |
| 12/27/2012 | WO2012177741A1 Pcsk9-binding polypeptides and methods of use |
| 12/27/2012 | WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 12/27/2012 | WO2012177653A2 Targeting the neuromuscular junction for treatment |
| 12/27/2012 | WO2012177595A1 Compositions and methods for the therapy and diagnosis of cancer |
| 12/27/2012 | WO2012177520A2 Oligopeptides and their use for treating infectious diseases |
| 12/27/2012 | WO2012177497A1 Method to inhibit neuropathic pain by intrathecal injection of protein phosphatases |
| 12/27/2012 | WO2012177481A2 Fibroblast growth factor receptor inhibition for the treatment of disease |
| 12/27/2012 | WO2012177443A2 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | WO2012177020A2 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| 12/27/2012 | WO2012176909A1 Tripropeptin derivative or pharmacologically acceptable salt thereof, and antibacterial agent |
| 12/27/2012 | WO2012176876A1 Method for producing protein preparation |
| 12/27/2012 | WO2012176862A1 Hydrophobic polymer compound having anticoagulant effect |
| 12/27/2012 | WO2012176853A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein |
| 12/27/2012 | WO2012176659A1 Production method for casein-derived peptides by lactic acid fermentation |
| 12/27/2012 | WO2012176658A1 Enzymatic production method for brain-function-improving peptides |
| 12/27/2012 | WO2012175745A1 Cell secreted proteins for the treatment of myocardial infarction |
| 12/27/2012 | WO2012175744A1 Relaxin proteins for use in the diagnosis, prevention or treatment of multiple sclerosis |
| 12/27/2012 | WO2012175700A1 Treatment of chronic hepatitis c with ifn-a5 combined with ifn-a2b in a cohort of patients |
| 12/27/2012 | WO2012175613A1 NKp46-MEDIATED NK CELL TUNING |
| 12/27/2012 | WO2012175611A1 Bioresorbable wound dressing |
| 12/27/2012 | WO2012175532A1 Modified antibiotic peptides having variable systemic release |
| 12/27/2012 | WO2012175481A1 Compositions and methods for treating leukemia |
| 12/27/2012 | WO2012175378A1 Ciliary neurotrophic factor variants |
| 12/27/2012 | WO2012175222A1 AN IL-15 AND IL-15Rα SUSHI DOMAIN BASED IMMUNOCYTOKINES |
| 12/27/2012 | WO2012174591A1 Prevention and treatment of acute inflammatory conditions |
| 12/27/2012 | WO2012154587A3 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents |
| 12/27/2012 | WO2012149481A8 Novel peptide inhibitors of serotonin 5-ht2c receptor:pten interaction |
| 12/27/2012 | WO2012142604A3 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9 |
| 12/27/2012 | WO2012142434A8 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 12/27/2012 | WO2012142410A3 Redox responsive polymeric nanocapsules for protein delivery |
| 12/27/2012 | WO2012139028A3 Anti-viral combination therapy |
| 12/27/2012 | WO2012136204A3 Preparation for improving the alcohol metabolism |
| 12/27/2012 | WO2012135422A3 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
| 12/27/2012 | WO2012134540A3 Injectable synthetic pur composite |
| 12/27/2012 | WO2012129335A3 Hyd1 peptides for relapsed cancer |
| 12/27/2012 | WO2012129237A3 Therapeutic agent for emphysema and copd |
| 12/27/2012 | WO2012127352A3 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo |
| 12/27/2012 | WO2012124998A3 Bio-pin |
| 12/27/2012 | WO2012118821A3 Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis |
| 12/27/2012 | WO2012102753A3 Metalloproteinase oligopeptides and their therapeutic use |
| 12/27/2012 | WO2012079088A3 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases |
| 12/27/2012 | WO2012075243A3 Methods and compositions for targeting sites of neovascular growth |
| 12/27/2012 | WO2012036437A9 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
| 12/27/2012 | WO2012031250A3 Compositions for labeling nerves and methods of use |
| 12/27/2012 | WO2010042891A3 Method for inducing pluripotency in cells |
| 12/27/2012 | US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues |
| 12/27/2012 | US20120331576 Pathogen Restriction Factors |
| 12/27/2012 | US20120331575 Transgenic non-human animals |
| 12/27/2012 | US20120331574 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329870 Methods for Treating or Preventing Restenosis and Other Vascular Proliferative Disorders |
| 12/27/2012 | US20120329833 Use of antagonists of the cbi receptor for the manufacture of a composition useful for the treatment of hepatic diseases |